restylane-lyft-logofacial-care-xs

Get UpLyfted

Natural-looking volume and definition for your cheeks

Restylane® Lyft is now approved by the FDA for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. This is in addition to treating moderate-to-severe facial wrinkles and folds, such as nasolabial folds (smile lines).

What Is Restylane Lyft?

As we age and our faces lose volume, some of us begin to look for ways to regain more definition in our cheeks without surgery. Restylane Lyft, formerly known as Perlane-L®, is an injectable hyaluronic acid gel used to correct volume loss and treat wrinkles in the face.

Restylane Lyft is the first and only FDA-approved filler indicated to provide lift to cheeks and add volume to correct and smooth smile lines (nasolabial folds).

This product should not be used by people with severe allergies or bleeding disorders.

1. Restylane Lyft Instructions for Use. Galderma Laboratories, L.P., Fort Worth, TX.

How does Restylane Lyft Work?

Over time, the natural fat that surrounds the cheeks begins to deteriorate, resulting in sagging skin, more prominent wrinkles and a reduction of volume. Through nonsurgical injections, Restylane Lyft is specifically designed to add fullness to the cheeks and midface area, which can result in a more natural-looking, youthful appearance.

Precise and natural-looking midface contour

Restylane Family

Restylane Lyft is just one member of the full Restylane family of products. Each treatment is a clear gel formulation of hyaluronic acid. They are specifically formulated to act like your body’s own naturally produced hyaluronic acid in patients 21 years of age and older.

Important Safety Information

Indications: Restylane® Lyft with Lidocaine is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds, and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21.